Study: NCT00899470

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Co-administration of Saxagliptin and Metformin IR, Fasted
Description: Participants received oral co-administration of a 2.5 mg tablet of saxagliptin and a 500 mg tablet of metformin immediate release (IR) under fasted conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fasting
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fasting conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fasting
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fasting conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fasting
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fasting conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fasting
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fasting conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Co-administration of Saxagliptin and Metformin IR, Fed
Description: Participants received oral co-administration of a 2.5 mg tablet of saxagliptin and a 500 mg tablet of metformin immediate release (IR) under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Co-administration of Saxagliptin and Metformin IR, Fed
Description: Participants received oral co-administration of a 2.5 mg tablet of saxagliptin and a 500 mg tablet of metformin immediate release (IR) under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Co-administration of Saxagliptin and Metformin IR, Fed
Description: Participants received oral co-administration of a 2.5 mg tablet of saxagliptin and a 500 mg tablet of metformin immediate release (IR) under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Co-administration of Saxagliptin and Metformin IR, Fed
Description: Participants received oral co-administration of a 2.5 mg tablet of saxagliptin and a 500 mg tablet of metformin immediate release (IR) under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fed
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fed
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fed
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fed conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin/Metformin, Fed
Description: Participants received a single oral dose of a fixed dose combination (FDC) tablet of 2.5 mg saxagliptin/500 mg metformin IR under fed conditions